跳至主要内容
欧盟官方标签名称词汇表条目 14153

KETOCONAZOLE

本记录确认了用于欧盟化妆品标签标示的官方通用成分名称。它本身并不能确认该物质获准使用、不受限制或安全。

全球证据概览

所解析的身份在 13 个已索引市场数据集中的 8 个有匹配的监管证据:8 条国家记录和 0 条欧盟附件记录。下方列出每项结果和证据缺口。

8 个市场有证据
已检查的市场
13
有证据的市场
8
证据缺口
5
已解析的标识符
10

已解析的物质身份

CAS:65277-42-187-10-567-96-9536-33-467-45-8443-48-167-20-960-56-01404-88-2
EC:265-667-4
成分索引记录:
KETOCONAZOLE
化妆品功能: NOT REPORTED

Ketoconazole is the heterocyclic compound that conforms to the formula

清单限制备注: II/1528

8 个匹配或报告的名称
KETOCONAZOLEKetoconazole; 1-[4-[4-[[(2SR,4RS)-2-(2,4-dichlorophenyl)-2-(imidazol-1-ylmethyl)-1,3-dioxolan-4-yl]methoxy]phenyl]piperazin-1-yl]ethanoneKetoconazole (1-[4-[4-[[(2SR,4RS)-2-(2,4-dichlorophenyl)-2-(imidazol-1-ylmethyl)-1,3-dioxolan-4-yl]methoxy]phenyl]piperazin-1-yl]ethenone)Ketoconazole; 1-[4-[4-[[(2SR,4RS)-2-(2,4-dichlorophenyl)-2-抗感染类药物,包括但不限于三溴沙 仑、抗生素类、二氢速甾醇、乙硫异烟 胺、呋喃唑酮、酮康唑、甲硝唑、呋喃 妥因、磺胺类药物(磺胺和其氨基的一 个或多个氢原子被取代的衍生物)及其 盐类、甲巯咪唑、短杆菌素等 — Anti-infectives, including but not limited to 3,4',5-Tribromosalicylanilide (Tribromsalan (INN) )(CAS No. 87-10-5), Antibiotics, Dihydrotachysterol (INN) (CAS No. 67-96-9), Ethionamide (INN) (CAS No. 536-33-4), Furazolidone (INN) (CAS No. 67-45-8), Ketoconazole (CAS No. 65277-42-1), Metronidazole (CAS No. 443-48-1), Nitrofurantoin (INN) (CAS No. 67-20-9), Sulphonamides (sulphanilamide and its derivatives obtained by substitution of one or more H-atoms of the -NH2 groups) and their salts, Thiamazole (INN) (CAS No. 60-56-0), Thyrothricine (CAS No. 1404-88-2)케토코나졸Cetoconazol (KETOCONAZOLE)Ketoconazole; 1-[4-[4-[[(2SR,4RS)-2-(2,4-dichlorophenyl)-2-(imidazol-1-ylmethyl)-1,3-dioxolan-4- yl]methoxy]phenyl] piperazin-1-yl]ethenone (CAS No. 65277-42-1)

全部 13 个市场的监管证据

打开每条匹配记录,查看其范围、浓度、条件、警示语和官方来源版本。

滑动或横向滚动以查看数据集覆盖范围和后续操作。

市场结果记录数据集含义 / 后续操作
European Union
EU
未找到匹配项0
Complete annex dataset
Regulation (EC) 1223/2009 consolidated to 1 May 2026
No annex match only means that these five annexes did not return a match; CosIng identity data and other EU obligations still need review.
Great Britain
GB
Prohibited1打开记录 1
Complete consolidated annex dataset
GB retained Regulation 1223/2009 schedules, effective 15 August 2026
请查看每条关联记录及其确切条件。
Canada
CA
未找到匹配项0
Complete Hotlist snapshot
Health Canada Cosmetic Ingredient Hotlist, 13 August 2025
The Hotlist is an administrative compliance tool, not an exhaustive safety approval list.
New Zealand
NZ
Prohibited1打开记录 1
Complete schedules dataset
Cosmetic Products Group Standard schedules effective 1 January 2026
请查看每条关联记录及其确切条件。
ASEAN
ASEAN
Prohibited1打开记录 1
Complete regional annex dataset
ASEAN Cosmetic Directive annexes 2026-1, 22 June 2026
请查看每条关联记录及其确切条件。
China
CN
Prohibited1打开记录 1
Complete prohibited catalogues plus official-source workflow
NMPA 2021 banned catalogues plus dynamic IECIC List I/List II system current since 2025
请查看每条关联记录及其确切条件。
Japan
JP
未找到匹配项0
Complete Standards appendices dataset
MHLW Standards for Cosmetics official English source and Japanese amendments checked for the imported snapshot
The Japanese text and subsequent notices are canonical; no local match is not a product-compliance conclusion.
South Korea
KR
Prohibited1打开记录 1
Complete current appendix dataset
MFDS Notice 2026-19, effective 18 March 2026
请查看每条关联记录及其确切条件。
United States
US
未找到匹配项0
Complete enumerated federal ingredient rules
eCFR Title 21 issue date 27 August 2026
FDA has no general approved-cosmetic-ingredient catalogue; absence from these sections is not approval or proof of safety.
Australia
AU
未找到匹配项0
Complete cosmetic-relevant Poisons Standard subset plus official workflow
Therapeutic Goods (Poisons Standard—June 2026) Instrument 2026
An AICIS Inventory match is not cosmetic approval; no Inventory match can indicate a new, exempted, reported or confidential introduction.
Brazil
BR
Prohibited1打开记录 1
Complete prohibited dataset plus current restricted-list workflow
ANVISA RDC 1.029/2026 and RDC 1.030/2026, published 15 June 2026
请查看每条关联记录及其确切条件。
India
IN
Prohibited1打开记录 1
Complete current Part 2 dataset plus official workflow for Parts 1, 3 and 4
Cosmetics Rules 2020 plus current BIS IS 4707 parts (1:2020, 2:2025, 3:2025, 4:2022)
请查看每条关联记录及其确切条件。
Saudi Arabia
SA
Prohibited1打开记录 1
Complete official list index
SFDA live prohibited/restricted lists, snapshot 30 August 2026
请查看每条关联记录及其确切条件。
没有与此筛选条件匹配的市场行。

匹配的市场记录和条件

化学身份与性质

CAS 1404-88-2 的 PubChem 二维化学结构
CAS 1404-88-2PubChem CID 452550

Tyrothricin

Tyrothricin is an antibiotic peptide complex produced and extracted from the aerobic Gram-positive bacillus Brevibacillus parabrevis which was previously categorized as Bacillus brevis and Bacillus aneurinolyticus. This complex is a mixture comprised of 60% tyrocidine cationic cyclic decapeptides (consisting largely of the six predominant tyrocidines, TrcA/A1, TrcB/B1, TrcC/C1, and other more minor contributors) and 40% neutral linear gramicidins (where valine-gramicidin A is often the major gramicidin present, although the mixture composition can vary). Moreover, tyrothricin possesses broad spectrum Gram-positive antibacterial and antifungal activity that has not seen many - if any - significant reportings of microbial resistance during the over 60 years of therapeutic use the complex has provided. Nevertheless, as tyrothricin is both cytolytic and hemolytic, it does demonstrate systemic toxicity, although certain formulations that are safe for human use like throat lozenges do exist. — DrugBank

IUPAC 名称
3-[(3R,6S,9S,12S,15S,17S,20S,22R,25S,28S)-20-(2-amino-2-oxoethyl)-9-(3-aminopropyl)-3,22,25-tribenzyl-15-[(4-hydroxyphenyl)methyl]-6-(2-methylpropyl)-2,5,8,11,14,18,21,24,27-nonaoxo-12-propan-2-yl-1,4,7,10,13,16,19,23,26-nonazabicyclo[26.3.0]hentriacontan-17-yl]propanoic acid
分子式
C65H85N11O13
分子量
1228.4 g/mol
精确质量
1227.63283181 Da
XLogP3
1.9
拓扑极性表面积
380.0 Ų
氢键供体
12
氢键受体
15
共价单元
1
已定义的立体中心
10

又称

BactratycinColtirotDermotricineHydrotricineMartricinTirotricinaTyrothricineSolutricine
另有 16 个已报告名称
TyrothricinumTyrodermTyrosurDubos crude crystalsTyri 10NSC-757363RefChem:192767D06AX08R02AB02S01AA05215-771-0PharothricettenBiothricinGinotricinaRinotricinaTriciderm
外部数据库标识符

于 2026-09-02 通过校验和有效的 CAS 匹配从美国国立卫生研究院 (NIH) PubChem 检索。化学性质不能取代本页的监管决定。

CAS 443-48-1 的 PubChem 二维化学结构
CAS 443-48-1PubChem CID 4173

Metronidazole

Metronidazole is a member of the class of imidazoles substituted at C-1, -2 and -5 with 2-hydroxyethyl, nitro and methyl groups respectively. It has activity against anaerobic bacteria and protozoa, and has a radiosensitising effect on hypoxic tumour cells. It may be given by mouth in tablets, or as the benzoate in an oral suspension. The hydrochloride salt can be used in intravenous infusions. Metronidazole is a prodrug and is selective for anaerobic bacteria due to their ability to intracellularly reduce the nitro group of metronidazole to give nitroso-containing intermediates. These can covalently bind to DNA, disrupting its helical structure, inducing DNA strand breaks and inhibiting bacterial nucleic acid synthesis, ultimately resulting in bacterial cell death. It has a role as a radiosensitizing agent, an antiamoebic agent, an antimicrobial agent, an antiparasitic agent, a xenobiotic, an antibacterial drug, a prodrug, an antitrichomonal drug and an environmental contaminant. It is a primary alcohol, a member of imidazoles and a C-nitro compound. It is a conjugate base of a metronidazole(1+). — ChEBI

IUPAC 名称
2-(2-methyl-5-nitroimidazol-1-yl)ethanol
分子式
C6H9N3O3
分子量
171.15 g/mol
精确质量
171.06439116 Da
XLogP3
0.0
拓扑极性表面积
83.9 Ų
氢键供体
1
氢键受体
4
共价单元
1
已定义的立体中心
0

又称

MetronidazolGineflavir2-Methyl-5-nitroimidazole-1-ethanolDeflamonOrvagilTrichazolMetroGelSanatrichom
另有 16 个已报告名称
AnagiardilDanizolMeronidalMetronidazMexibolTrichocideTricocetTrivazolVagilenVagimidArilinClontKlionBayer 5360MetronidazoloAcromona
外部数据库标识符

于 2026-08-31 通过校验和有效的 CAS 匹配从美国国立卫生研究院 (NIH) PubChem 检索。化学性质不能取代本页的监管决定。

CAS 536-33-4 的 PubChem 二维化学结构
CAS 536-33-4PubChem CID 2761171

Ethionamide

Ethionamide is a thiocarboxamide that is pyridine-4-carbothioamide substituted by an ethyl group at position 2. A prodrug that undergoes metabolic activation by conversion to the corresponding S-oxide. It has a role as an antitubercular agent, an antilipemic drug, a leprostatic drug, a fatty acid synthesis inhibitor and a prodrug. It is a member of pyridines and a thiocarboxamide. — ChEBI

IUPAC 名称
2-ethylpyridine-4-carbothioamide
分子式
C8H10N2S
分子量
166.25 g/mol
精确质量
166.05646950 Da
XLogP3
1.1
拓扑极性表面积
71.0 Ų
氢键供体
1
氢键受体
2
共价单元
1
已定义的立体中心
0

又称

TrecatorEthioniamideAmidazineEthinamideEthyonomideEtionamidEtioniamid2-Ethylthioisonicotinamide
另有 16 个已报告名称
NizotinEthylisothiamideTeberusTrecator-SCAmidazinBayer 5312IridocinIridozinSertinonThianideTrescatylEtionid4-Pyridinecarbothioamide, 2-ethyl-EtionizinEtionizineEthimide
外部数据库标识符

于 2026-08-31 通过校验和有效的 CAS 匹配从美国国立卫生研究院 (NIH) PubChem 检索。化学性质不能取代本页的监管决定。

CAS 60-56-0 的 PubChem 二维化学结构
CAS 60-56-0PubChem CID 1349907

Methimazole

Methimazole is a member of the class of imidazoles that it imidazole-2-thione in which a methyl group replaces the hydrogen which is attached to a nitrogen. It has a role as an antithyroid drug. — ChEBI

IUPAC 名称
3-methyl-1H-imidazole-2-thione
分子式
C4H6N2S
分子量
114.17 g/mol
精确质量
114.02516937 Da
XLogP3
-0.3
拓扑极性表面积
47.4 Ų
氢键供体
1
氢键受体
1
共价单元
1
已定义的立体中心
0

又称

thiamazoleTapazole1-Methyl-1H-imidazole-2-thiolMethimazol1-Methylimidazole-2-thiolMercazolylThiamazolMercazole
另有 16 个已报告名称
ThymidazolThymidazoleFavistanMercaptazoleMetothyrineMetazoloMetothyrinStrumazolThycapzolDanantizolFrentiroxMerkazolilMetotirinThacapzolBasolanMercasolyl
外部数据库标识符

于 2026-08-31 通过校验和有效的 CAS 匹配从美国国立卫生研究院 (NIH) PubChem 检索。化学性质不能取代本页的监管决定。

CAS 65277-42-1 的 PubChem 二维化学结构
CAS 65277-42-1PubChem CID 47576

Ketoconazole

(2S,4R)-ketoconazole is a cis-1-acetyl-4-(4-{[2-(2,4-dichlorophenyl)-2-(1H-imidazol-1-ylmethyl)-1,3-dioxolan-4-yl]methoxy}phenyl)piperazine which dioxolane moiety has (2S,4R)-configuration. It is an enantiomer of a (2R,4S)-ketoconazole. — ChEBI

IUPAC 名称
1-[4-[4-[[(2S,4R)-2-(2,4-dichlorophenyl)-2-(imidazol-1-ylmethyl)-1,3-dioxolan-4-yl]methoxy]phenyl]piperazin-1-yl]ethanone
分子式
C26H28Cl2N4O4
分子量
531.4 g/mol
精确质量
530.1487608 Da
XLogP3
4.3
拓扑极性表面积
69.1 Ų
氢键供体
0
氢键受体
6
共价单元
1
已定义的立体中心
2

又称

NizoralPanfungolKetodermFungarestFungoralKetoisdinKetozoleExtina
另有 16 个已报告名称
Orifungal MNizoral a-DKetoconazolXolegelKetoconazolumPiperazine, 1-acetyl-4-[4-[[2-(2,4-dichlorophenyl)-2-(1H-imidazol-1-ylmethyl)-1,3-dioxolan-4-yl]methoxy]phenyl]-, cis-R 41400R9400W927ICHEBI:47519Piperazine, 1-acetyl-4-(4-((2-(2,4-dichlorophenyl)-2-(1H-imidazol-1-ylmethyl)-1,3-dioxolan-4-yl)methoxy)phenyl)-, cis-R-41400DandrazolDandridKetopineNizorelle(+-)-cis-1-Acetyl-4-(p-((2-(2,4-dichlorophenyl)-2-(imidazol-1-ylmethyl)-1,3-dioxolan-4-yl)methoxy)phenyl)piperazine
外部数据库标识符

于 2026-08-31 通过校验和有效的 CAS 匹配从美国国立卫生研究院 (NIH) PubChem 检索。化学性质不能取代本页的监管决定。

CAS 67-20-9 的 PubChem 二维化学结构
CAS 67-20-9PubChem CID 6604200

Nitrofurantoin

Nitrofurantoin is an imidazolidine-2,4-dione that is hydantoin substituted at position 1 by a [(5-nitro-2-furyl)methylene]amino group. An antibiotic that damages bacterial DNA. It has a role as an antiinfective agent, an antibacterial drug and a hepatotoxic agent. It is an imidazolidine-2,4-dione, an organonitrogen heterocyclic antibiotic, an organooxygen heterocyclic antibiotic and a nitrofuran antibiotic. It is functionally related to a semicarbazide. — ChEBI

IUPAC 名称
1-[(E)-(5-nitrofuran-2-yl)methylideneamino]imidazolidine-2,4-dione
分子式
C8H6N4O5
分子量
238.16 g/mol
精确质量
238.03381930 Da
XLogP3
-0.5
拓扑极性表面积
121.0 Ų
氢键供体
1
氢键受体
6
共价单元
1
已定义的立体中心
0

又称

FuradantinMacrodantin5-NitrofurantoinFuradantoinFuradoninFuradontinNifurantinFuralan
另有 16 个已报告名称
MacrobidOrafuranParfuranUrantoinIturanNitrofurantoinaNitrofurantoineBerkfurinChemiofuranFurachelFuradoineFuradonineFuratoinFurobactinaNovofuranTrantoin
外部数据库标识符

于 2026-08-31 通过校验和有效的 CAS 匹配从美国国立卫生研究院 (NIH) PubChem 检索。化学性质不能取代本页的监管决定。

CAS 67-45-8 的 PubChem 二维化学结构
CAS 67-45-8PubChem CID 5323714

Furazolidone

Furazolidone is a member of the class of oxazolidines that is 1,3-oxazolidin-2-one in which the hydrogen attached to the nitrogen is replaced by an N-{[(5-nitro-2-furyl)methylene]amino} group. It has antibacterial and antiprotozoal properties, and is used in the treatment of giardiasis and cholera. It has a role as an antiinfective agent, an antibacterial drug, an EC 1.4.3.4 (monoamine oxidase) inhibitor and an antitrichomonal drug. It is a member of oxazolidines and a nitrofuran antibiotic. — ChEBI

IUPAC 名称
3-[(E)-(5-nitrofuran-2-yl)methylideneamino]-1,3-oxazolidin-2-one
分子式
C8H7N3O5
分子量
225.16 g/mol
精确质量
225.03857033 Da
XLogP3
-0.1
拓扑极性表面积
101.0 Ų
氢键供体
0
氢键受体
6
共价单元
1
已定义的立体中心
0

又称

FuroxoneNitrofurazolidoneFurazolidineNitrofuroxonDiafuronFurazolFuridonNeftin
另有 16 个已报告名称
FuraxoneFurazolidonFuroxaneNifulidoneFurazonFuroxonGiarlamNitrofurazolidonumFurozolidineNifurazolidoneTikofuranTrichofuronTricofuronCoryziumFuraxonFuroxal
外部数据库标识符

于 2026-08-31 通过校验和有效的 CAS 匹配从美国国立卫生研究院 (NIH) PubChem 检索。化学性质不能取代本页的监管决定。

CAS 67-96-9 的 PubChem 二维化学结构
CAS 67-96-9PubChem CID 5311071

Dihydrotachysterol

Dihydrotachysterol is a hydroxy seco-steroid that is 9,10-secoergosta-5,7,22-triene substituted by a hydroxy group at position 3. A synthetic analogue of vitamin D that acts a bone density conservation agent. It has a role as a bone density conservation agent. It is a vitamin D, a seco-ergostane and a hydroxy seco-steroid. — ChEBI

IUPAC 名称
trans-(1S,3E,4S)-3-[(2E)-2-[(1R,3aS,7aR)-1-[(E,2R,5R)-5,6-dimethylhept-3-en-2-yl]-7a-methyl-2,3,3a,5,6,7-hexahydro-1H-inden-4-ylidene]ethylidene]-4-methylcyclohexan-1-ol
分子式
C28H46O
分子量
398.7 g/mol
精确质量
398.354866087 Da
XLogP3
7.7
拓扑极性表面积
20.2 Ų
氢键供体
1
氢键受体
1
共价单元
1
已定义的立体中心
7

又称

DichystrolumAntitanilHytakerolTachystinDihidrotaquisterolDihydrotachysterol2DihydralDygratyl
另有 16 个已报告名称
ParterolTachyrolAnti-tetany substance 10DihydrotachysterolumDHT2DiidrotachisteroloDihydrotachysterol 2AT 10Tachysterol, dihydro-Tachysterol2, dihydro-A.T. 10R5LM3H112RTachysterol dihydro derivativeCHEBI:45919,10-Secoergosta-5,7,22-trien-3beta-ol(1S,3E,4S)-3-{2-[(1R,3aS,4E,7aR)-1-[(2R,3E,5R)-5,6-dimethylhept-3-en-2-yl]-7a-methyl-octahydro-1H-inden-4-ylidene]ethylidene}-4-methylcyclohexan-1-ol
外部数据库标识符

于 2026-08-31 通过校验和有效的 CAS 匹配从美国国立卫生研究院 (NIH) PubChem 检索。化学性质不能取代本页的监管决定。

CAS 87-10-5 的 PubChem 二维化学结构
CAS 87-10-5PubChem CID 14868

3,4',5-Tribromosalicylanilide

Tribromosalicylanilide is a salicylanilide derivative with bromo- substituents at C-3 and C-5 of the salicylate moiety and at C-4 of the anilide moiety. It is functionally related to a salicylanilide. — ChEBI

IUPAC 名称
3,5-dibromo-N-(4-bromophenyl)-2-hydroxybenzamide
分子式
C13H8Br3NO2
分子量
449.92 g/mol
精确质量
448.80847 Da
XLogP3
5.0
拓扑极性表面积
49.3 Ų
氢键供体
2
氢键受体
2
共价单元
1
已定义的立体中心
0

又称

TribromsalanTemasept IVTrisanilTuasol 100ET-394NSC-205266MCE3VTF0OSalicylanilide, 3,4',5-tribromo-
另有 16 个已报告名称
BENZAMIDE, 3,5-DIBROMO-N-(4-BROMOPHENYL)-2-HYDROXY-WR-34912CHEBI:127105DiapheneTemaceptRefChem:899088201-723-63,5,4'-TribromosalicylanilideAgramedTRIBROMOSALICYLANILIDETemasept IITrisanylTempasept IISherstat TBSVancide TBSTribromsalanum
外部数据库标识符

于 2026-09-02 通过校验和有效的 CAS 匹配从美国国立卫生研究院 (NIH) PubChem 检索。化学性质不能取代本页的监管决定。

进一步查看此记录

在配方中筛查打开独立对比

官方来源与范围

导入自委员会实施决定 (EU) 2025/1175(数据集版本 EU 2025/1175)。词汇表为第 19(1)(g) 条所要求的成分表提供通用成分名称;它不是准许清单或安全清单。

打开官方决定